Cardiology Research and Practice / 2018 / Article / Tab 1

Research Article

Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts

Table 1

Baseline characteristics and risk factors.

VariablesSxSIILow ≤21.5SxSIIMid 21.5–30.6SxSIIHigh ≥30.6 value

Age52.3 ± 7.460.5 ± 9.571.7 ± 10.2N/A
Gender (male)239 (97.6)205 (83.7)146 (59.8)N/A
ACS0.001
STEMI167 (68.2)181 (73.9)189 (77.5)
NSTE-ACS65 (26.5)63 (25.7.4)53 (21.7)
Unstable angina13 (5.3)1 (0.4)2 (0.8)
Hypertension100 (43.1)122 (51.7)155 (68)<0.001
History of dyslipidemia143 (61.9)140 (59.6)138 (60.8)0.878
Diabetes mellitus28 (12.1)41 (17.4)39 (17.1)0.207
History of smoking207 (84.5)188 (76.7)142 (59.2)<0.001
History of CAD72 (31.9)57 (24.2)38 (17.5)0.002
Prior MI11 (4.7)20 (8.5)25 (11)0.049
Prior PCI19 (8.2)25 (10.5)28 (12.3)0.347
History of PVD0 (0)1 (0.4)23 (9.4)N/A
History of COPD3 (1.2)6 (2.4)15 (6.1)N/A
Killip score ≥221 (8.5)31 (12.7)46 (18.9)0.003
Prehospital resuscitation16 (6.5)8 (3.3)10 (4.1)0.226
Vasopressors5 (2)4 (1.6)15 (6.1)0.007
IABP3 (1.2)9 (3.7)33 (13.5)<0.001
BMI (kg/m2)27.7 ± 3.927.5 ± 4.225.6 ± 3.6<0.001
HsTnT (ug/l)0.14 (0.04/0.51)0.18 (0.04/0.67)0.24 (0.08/0.73)0.008
CK-MB (U/l)24.3 (11/57)28.5 (12/68)34 (14/66)0.104
NT-proBNP (ng/l)137 (47/311)256 (95/701)586 (195/1960)<0.001
eGFR (ml/min/1.73 m2)127.8 ± 30.8106.9 ± 33.669.5 ± 29.4N/A
Fasting glucose (mmol/l)6.8 ± 2.27.4 ± 2.97.8 ± 3.40.001
LVEF (%)55.7 ± 7.450.7 ± 10.245.9 ± 12.4N/A

Depicted are counts, n incidence (%) or mean ± SD or median (25/75) percentile. Variables are included in the score; value reported as N/A. CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction.